ZHU Danhua, ZHENG Guimei, SUN Zhilian, LIAO Jingbo, LI Honghui. Application of flash glucose monitoring system combined with metformin in overweight patients diagnosed as primary type 2 diabetes[J]. Journal of Clinical Medicine in Practice, 2020, 24(2): 9-12. DOI: 10.7619/jcmp.202002003
Citation: ZHU Danhua, ZHENG Guimei, SUN Zhilian, LIAO Jingbo, LI Honghui. Application of flash glucose monitoring system combined with metformin in overweight patients diagnosed as primary type 2 diabetes[J]. Journal of Clinical Medicine in Practice, 2020, 24(2): 9-12. DOI: 10.7619/jcmp.202002003

Application of flash glucose monitoring system combined with metformin in overweight patients diagnosed as primary type 2 diabetes

More Information
  • Received Date: November 17, 2019
  • Available Online: August 26, 2020
  • Published Date: August 26, 2020
  • Objective To investigate the differences in the establishment of healthy lifestyle patterns and metabolic indicators in overweight patients newly diagnosed as type 2 diabetes by flash glucose monitoring versus traditional fingertip blood glucose monitoring. Methods A total of 102 overweight patients newly diagnosed as type 2 diabetes were randomly divided into study group and control group. The study group treated with metformin and flash glucose monitoring system for blood glucose management and life style intervention. The control group was treated with metformin and periodically detection of blood glucose level by fingertip blood glucose monitoring. The blood glucose at different time points were recorded. The metabolic indicators such as body weight, waist circumference, blood glucose, blood lipids and islet function before and after intervention were compared and the changes in self-administration behavior scale(SDSCA)scores of these patients were observed. Results After 14 days of intervention, the SDSCA scores of both two groups were higher than baseline, and the difference was statistically significant(P<0.05). The variations of body weight(△BW), body mass index(△BMI), waist circumference(△WC), triglyceride(△TG), fasting plasma glucose(△FPG), insulin(△Ins), uric acid(△UA), △SDSCA before and after intervention of two groups were statistically significant(P<0.05), but the variations of △TC(total cholesterol), low density lipoprotein cholesterol(△LDL-C), high density lipoprotein cholesterol(△HDL-C)- showed no statistically significant(P>0.05). During 14-day intervention period, the difference of standard deviation of blood glucose(SDBG)and mean amplitude of glycemic excursions(MAGE)were lower in the study group than in the controgroup(P< 0.05). Conclusion The flash glucose monitoring system promotes healthy life style compared with traditional fingertip blood glucose monitoring. It is beneficial for overweight patients newly diagnosed as type 2 diabetes to control weight, blood sugar and blood lipids, relieve insulin resistance and improve islet function.
  • 顾景范. 《中国居民营养与慢性病状况报告(2015)》解读[J]. 营养学报, 2016, 38(6): 525-529.
    张璐, 杨跃进, 温瑞, 等. 超重、肥胖和腹型肥胖与心血管代谢性疾病的关联研究[J]. 现代预防医学, 2016, 43(21): 3887-3891.
    罗丹, 常向云, 孙侃. 不同BMI代谢综合征患者罹患动脉粥样硬化性心脑血管疾病的回顾性研究[J]. 石河子大学学报: 自然科学版, 2018, 36(1): 27-30.
    顾梦佳. 体质指数与人群全肿瘤死亡风险的关联研究[D]. 杭州: 浙江大学, 2016.
    蔡玲莉, 周健, 贾伟平. 瞬感扫描式葡萄糖监测系统的临床研究进展[J]. 中华内科杂志, 2018, 57(11): 858-861.
    母义明, 纪立农, 李春霖, 等. 二甲双胍临床应用专家共识(2018年版)[J]. 中国糖尿病杂志, 2019, 27(3): 161-173.
    程彦臻, 陈宏, 杨帆, 等. 广东省超重、肥胖2型糖尿病患者慢性并发症及合并症发病情况调查[J]. 山东医药, 2016, 56(31): 52-54.
    石立, 李德, 汤晓强, 等. 肥胖糖尿病患者腹内脂肪含量与脂肪细胞因子、胰岛素抵抗相关性研究[J]. 实用临床医药杂志, 2016, 20(21): 38-40.
    彭朝胜, 曹悦鞍, 刘淑云, 等. 肥胖患者血糖波动的特点[J]. 现代医学, 2011, 39(4): 424-426.
    Al Hayek A A, Robert A A, Al Dawish M A. Evaluation of FreeStyle libre flash glucose monitoring system on glycemic control, health-related quality of life, and fear of hypoglycemia in patients with type 1 diabetes[J]. Clin Med Insights Endocrinol Diabetes, 2017, 10: 1179551417746957.
    刘雪辉, 杨婷, 高珊. 动态血糖监测应用于2型糖尿病患者健康教育的效果评价[J]. 中国临床研究, 2014, 27(8): 1013-1016.
    孙正凯, 魏进, 韩玉亭. 动态血糖监测系统对2型糖尿病患者强化治疗中血糖波动监测的价值[J]. 山东医药, 2016, 56(37): 69-71.
  • Related Articles

    [1]LIU Xiaohong, LI Mei, WANG Fengyun, SI Yuchen, DU Xiaoli, SHI Liangliang, SHAO Haiou, CHEN Li, ZHANG Hongyan. Effect of modified Qiankun Yudan Decoction combined with leuprorelin acetate on serum carbohydrate antigen 125 and recurrence rate in patients with adenomyosis[J]. Journal of Clinical Medicine in Practice, 2023, 27(18): 133-137. DOI: 10.7619/jcmp.20231988
    [2]HUANG Sanxiu. Value of HIF-α and JAK protein levels in diagnosis of patients with endometriosis[J]. Journal of Clinical Medicine in Practice, 2016, (9): 70-72. DOI: 10.7619/jcmp.201609020
    [4]ZHAO Jumei, WANG Qi, CHENG Jing, JIANG Yuanqiong. Observation of the integrated value of different doses of mifepristone for patients with endometriosis[J]. Journal of Clinical Medicine in Practice, 2013, (15): 144-146. DOI: 10.7619/jcmp.201315055
    [5]JIANG Jingxia. A comparative study of serum C-reactive protein levels before and after conservative medical treatment in patients with endometrial endometriosis[J]. Journal of Clinical Medicine in Practice, 2012, (23): 166-167.
    [7]YAO Li-fen, MAO Yun-dong, WANG Fu-xin. Preliminary study of vinculin expression in endometriosis[J]. Journal of Clinical Medicine in Practice, 2011, (11): 80-83. DOI: 10.3969/j.issn.1672-2353.2011.11.026
    [10]MEASUREMENT OF VASCULAR ENDOTHLIAL GROWTH FACTOR AND INTERLEUKIN-8 LEVELS IN PERITONEAL FLUID OF PATIENTS WITH ENDOMETRIOSIS[J]. Journal of Clinical Medicine in Practice, 2002, (2): 122-124. DOI: 10.3969/j.issn.1672-2353.2002.02.011
  • Cited by

    Periodical cited type(1)

    1. 刘钟城,龙美春,肖志明,郭勤. 原发性小肠肿瘤临床特征分析. 医学信息. 2021(18): 122-125 .

    Other cited types(0)

Catalog

    Article views (346) PDF downloads (9) Cited by(1)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return